About the Authors
- Caroline J. Voskens
-
Affiliation Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
- Simone M. Goldinger
-
Affiliation Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- Carmen Loquai
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, University Hospital Mainz, Mainz, Germany
- Caroline Robert
-
Affiliation Institute Gustave Roussy, Department of Dermatology, Villejuif, France
- Katharina C. Kaehler
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, University Hospital Kiel, Kiel, Germany
- Carola Berking
-
Affiliation Department of Dermatology and Allergology, University of Munich LMU, Munich, Germany
- Tanja Bergmann
-
Affiliation Department of Internal Medicine (Gastroenterology, Endocrinology, and Pneumology), University Hospital Erlangen, Erlangen, Germany
- Clemens L. Bockmeyer
-
Affiliation Department of Dermatology and Allergy/Department of Pathology, Skin Cancer Center Hannover/Hannover Medical School, Hannover, Germany
- Thomas Eigentler
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
- Michael Fluck
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, Hospital Hornheide, Münster, Germany
- Claus Garbe
-
Affiliation Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
- Ralf Gutzmer
-
Affiliation Department of Dermatology and Allergy/Department of Pathology, Skin Cancer Center Hannover/Hannover Medical School, Hannover, Germany
- Stephan Grabbe
-
Affiliation Department of Dermatology, University Hospital Mainz, Mainz, Germany
- Axel Hauschild
-
Affiliation Department of Dermatology, University Hospital Kiel, Kiel, Germany
- Rüdiger Hein
-
Affiliation Department of Dermatology/III. Medical Department, Technische Universität München, München, Germany
- Gheorghe Hundorfean
-
Affiliation Department of Internal Medicine (Gastroenterology, Endocrinology, and Pneumology), University Hospital Erlangen, Erlangen, Germany
- Armin Justich
-
Affiliation Department of Dermatology, University Hospital Graz, Graz, Austria
- Ullrich Keller
-
Affiliation Department of Dermatology/III. Medical Department, Technische Universität München, München, Germany
- Christina Klein
-
Affiliation Department of Dermatology, University Hospital Mainz, Mainz, Germany
- Christine Mateus
-
Affiliation Institute Gustave Roussy, Department of Dermatology, Villejuif, France
- Peter Mohr
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany
- Sylvie Paetzold
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, University Hospital Frankfurt, Frankfurt, Germany
- Imke Satzger
-
Affiliation Department of Dermatology and Allergy/Department of Pathology, Skin Cancer Center Hannover/Hannover Medical School, Hannover, Germany
- Dirk Schadendorf
-
Affiliation Department of Dermatology, University Hospital Essen, Essen, Germany
- Marc Schlaeppi
-
Affiliation Department of Oncology/Hematology and Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
- Gerold Schuler
-
Affiliation Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
- Beatrice Schuler-Thurner
-
Affiliation Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
- Uwe Trefzer
-
Affiliation Department of Dermatology, University Hospital Charité Berlin, Berlin, Germany
- Jens Ulrich
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, Hospital Quedlinburg, Quedlinburg, Germany
- Julia Vaubel
-
Affiliation Department of Dermatology, University Hospital Essen, Essen, Germany
- Roger von Moos
-
Affiliation Department of Dermatology, Cantonal Hospital Graubünden, Chur, Switzerland
- Patrik Weder
-
Affiliation Department of Oncology/Hematology and Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
- Tabea Wilhelm
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, University Hospital Charité Berlin, Berlin, Germany
- Daniela Göppner
-
¶For the ipilimumab network.
Affiliation Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany
- Reinhard Dummer
-
Affiliation Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- Lucie M. Heinzerling
-
* E-mail: lheinzer@post.harvard.edu
¶For the ipilimumab network.
Affiliations Department of Dermatology, University Hospital Erlangen, Erlangen, Germany, Department of Oncology/Hematology and Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
Competing Interests
The authors have read the journal’s policy and have the following conflict: Several authors are member of local and regional BMS-ipilimumab advisory boards. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LMH SP DG CJV. Analyzed the data: LMH CJV. Contributed reagents/materials/analysis tools: SMG CL CR KK TB C. Berking TE MF CG RG AH RH GH AJ UK CK CM PM SP IS DS MS BS UT JU JV RvM PW TW DG RD. Wrote the paper: LMH CJV. Designed the figures: CL PW RvM C. Bockmeyer. Critically reviewed the manuscript: LMH CJV SG C. Berking GS RD.